chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Drop finger in digits of hands; Pain; This spontaneous case was reported by a consumer and describes the occurrence of MALLET FINGER (Drop finger in digits of hands) and PAIN (Pain) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Rheumatoid arthritis.    No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) CF. On an unknown date, ADALIMUMAB (HUMIRA) (Subcutaneous) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced MALLET FINGER (Drop finger in digits of hands) and PAIN (Pain). At the time of the report, MALLET FINGER (Drop finger in digits of hands) and PAIN (Pain) had not resolved.            It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. No concomitant medications were reported. No treatment medications were reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Headaches almost daily since vaccine; Tinnitus got much worse hours after vaccine and continues; 3 bouts of lethargy since the vaccine; This is a spontaneous report from a contactable nurse, the patient. A 52-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3180) via an unspecified route of administration in the right arm on 13Aug2021 at 14:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included small intestinal bacterial overgrowth (SIBO), irritable bowel syndrome (IBS), tinnitus and allergy to peanuts. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included alprazolam (XANAX) as needed (prn) at night taken for an unknown indication from an unknown date and unknown if ongoing. On 13Aug2021 at 17:00, the patient experienced headaches almost daily since vaccine. Tinnitus got much worse hours after vaccine and continued. The patient also experienced 3 bouts of lethargy since she had the vaccine. It was reported that the patient did not plan on getting second 'bc' if side effects. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were taken as a result of event headaches which included treatment with sumatriptan succinate (IMITREX). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headaches almost daily since vaccine, tinnitus got much worse hours after vaccine and continued, and 3 bouts of lethargy since the vaccine were not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
This initial spontaneous case received, was received from nurse on 16-Nov-2017, concerning a 68-year-old, adult, female patient. The patient surgical history included cancer surgery and the patient was a smoker. The concomitant medications were not reported. On 17-Oct-2017, the patient was administered with FLUCELVAX QIV (dose: 0.5ml, route of administration: intramuscular, anatomical location: left deltoid, batch number: 195211, and expiry date: Mar-2018). On the same day of vaccination, patient experienced soreness in arm after receiving the vaccine, symptom resolved within one hour. At the time of this report, the patient was completely recovered from the event. The reporter assessed the case as non-serious.
Vaccine administered about 1 pm. "Hives started in the afternoon/, fever, chills, muscle aches. Chest "fill up" almost like an asthma attack, chest congestion, coughing with heart racing lasting about 6 hours." Also developed headache, states gets migraines.
Employee return to Employee Health stating "I am dizzy and light headed." Had employee lay on exam table took BP 160/110 pulse 88 respiration 20 O2 sat 100%.  Complains of SOB with head down, elevated head.  Denies sensation of throat closing.  Called 911 to send to ER for evaluation of symptoms.
Mostly tired/ Fatigue; Headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Mostly tired/ Fatigue) and HEADACHE (Headache) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Mostly tired/ Fatigue) and HEADACHE (Headache). At the time of the report, FATIGUE (Mostly tired/ Fatigue) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant product use was reported.  No treatment information was provided.  After first dose, the patient experienced fatigue, headache and was mostly tired.   This case was linked to MOD-2021-373427, MOD-2021-373467 (Patient Link).
Initial information received on 15-Jan-2019 regarding an unsolicited valid non-serious case received from a physician by phone. This case involves a 7 years old patient who experienced an allergic reaction to last year's FLUZONE QUADRIVALENT, while he/she received vaccine FLUZONE QUADRIVALENT. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications were not reported. On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot number, expiry date, dose, dose in series, route and site of administration were not reported). On an unspecified date, the patient developed a non-serious an allergic reaction to last year's FLUZONE QUADRIVALENT following the administration of INFLUENZA QUADRIVAL A-B VACCINE. No Lab data was reported. Final diagnosis was an allergic reaction to last year's FLUZONE QUADRIVALENT. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for an allergic reaction to last year's FLUZONE QUADRIVALENT. Documents held by the sender: none.
I experienced two days later, nausea and fatigue and headaches in the frontal lobe and around and behind the eyes. On day 3-4; racing pulse ad felt breathless. I also felt fatigued, with shooting pain to my right arm. This pain comes and goes. I also have brain fog. My leg pain comes and goes. I have migraine headaches with fatigue, cough, nausea and sputum. I went to an acupuncturist which has helped a lot and will be going tomorrow for another session.
Right internal cheek is numb. Bottom, medial tongue is numb. Have some feeling and can voluntarily move right cheek and tongue.  Numbness feels similar to getting a numbing shot at the dentist.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Bump at the site of injection/big Walsh looking like bump/ swelling/puffy), VACCINATION SITE PAIN (It hurts) and VACCINATION SITE PRURITUS (Its itching) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination. Concurrent medical conditions included Tetanus. Concomitant products included ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication.On 01-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Bump at the site of injection/big Walsh looking like bump/ swelling/puffy), VACCINATION SITE PAIN (It hurts) and VACCINATION SITE PRURITUS (Its itching). At the time of the report, VACCINATION SITE SWELLING (Bump at the site of injection/big Walsh looking like bump/ swelling/puffy), VACCINATION SITE PAIN (It hurts) and VACCINATION SITE PRURITUS (Its itching) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.Treatment information was not provided by the reporter
Self-attestation on database allowed patient to sign up for Moderna, despite being younger than 18 when administered.
pt devel 2 swollen, indurated erythematous lymph nodes about 6hr a/1st dose;1 in axilla & i in groin size of pea;noted 1 enlarged & tender node p/2nd dose axilla;1 enlarged & tender node p/4th dose;
Patient was given swine flu vaccine on 10/29/09 at approx. 2:00 PM. He started with a rash from head to toe the same day at approx 6:00 PM. Rash is not bothering him and no treatment required.
tightness in my face; slight lightheadedness; something akin to a hotflash; heart beat became unnervingly very rapid; elevated blood pressure (between 150 and 160 as the upper number with a heart beat of 110 bpm; This is a spontaneous report from a contactable consumer (patient) reported himself. A 37-years-old male patient received first dose of BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, batch/lot number: EW0151), via an unspecified route of administration in left arm on 07Apr2021 at 11:00 (at the age of 37-years-old) as dose 1, single for COVID-19 immunisation. Facility type vaccine reported as other. The patient's medical history was reported as none. No known allergies. The patient concomitant medications were not reported. The patient did not receive any other vaccine in four weeks. The patient was not diagnosed with Covid-19, prior vaccination. The patient was not tested positive for covid-19, post vaccination. On 07Apr2021 at 11:00, the patient experienced within the first 5 minutes after receiving the shot, I began having tightness in my face, slight lightheadedness, something akin to a hotflash, and my heart beat became unnervingly very rapid. I went with an EMT to get checkout. I was told I had elevated blood pressure (between 150 and 160 as the upper number with a heart beat of 110 bpm- I usually sit between 115/70 and 128/74 and around 68 bpm). I was told my blood oxygen looked normal by the EMT. After about 1-2 hours after the shot, I was fine. My blood pressure and heartbeat returned to my normal levels. The patient did not received treatment for the events. The outcome of the events was recovered on an unspecified date.  No follow-up attempts are possible. No further information is expected.
Mom called stating pt had bruising and hx of ITP after Dtap vaccine age 4.
About one week after receiving the injection, I began to notice a hard lump about the size of ½ of a golf ball or small chicken egg. It was warm to the touch and itched a bit. Also the skin over the lump area was red and had a different texture. It felt a little like tiny bumps. I'm reporting this 11 days after receiving the injection. I still have a red area about 2" x 1" and is slightly itchy; but hard lump is gone.
pt states she got her 2nd Shringix vax and high dose flu vax at the same time and that night you woke up at about 1:00 AM to go to the bathroom.  She was having a very sharp pain in her chest.  She went back to bed to relax.  The next morning she told her husband that she felt like she may have had a heart attack during the night.   Pt wanted to make note that she had double vision on 12/15/2021 and tested positive for Covid 19 on 12/17/2021.  She had an EKG and CT scan on 1/22/2021 with abnormal results -left access deviation septal infarct that she will discuss w/ her Neurologist Dr. on 3/5/2021.   She feels like this is a snowball affect after taking both of these vaccines in September.
ANAPHYLAXIS; This solicited report received from a consumer concerned a 53 year old male of an unspecified race and ethnic origin. The patient's weight, height, and medical history were not reported. The patient initiated treatment with covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number: unknown, expiry: unknown) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  It was reported that eleven days after vaccination, the patient started experiencing body itching which he thought was due to being outside in a wooded area and getting bit by something. The itching got better about 3 days later, but then got much worse and eventually led to lip swelling. It was stated under assessment plan that patient had allergic angioedema (recurrent episodes of urticaria and angioedema, with swelling of lips (subsumed under anaphylaxis)). The patient had no swelling of tongue or sensation of throat closing, trigger was unclear and needed referral to an allergist for allergy testing. It was also reported that prednisone, Zyrtec, complete blood count (CBC) and comprehensive metabolic panel (CMP) were all ordered for the patient.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable.  The outcome of anaphylaxis was not reported. The reporter considered the causality between covid-19 vaccine ad26.cov2.s, and anaphylaxis as related.  This report was serious (Other Medically Important Condition).; Sender's Comments: V0:20220657833-covid-19 vaccine ad26.cov2.s-Anaphylaxis. This event(s) is labeled per RSI and is therefore considered potentially related.
ADMINISTRATION ERROR: Patient for booster dose of PFIZER without 6 months between second and third dose. Male patient 60 year old needs third dose and vaccine card replacement. At the time of confirming his information in the system. Nurse, proceeds to vaccinate the patient without the patient corroboration.
After about 5 days from second vaccination, went to the hospital with bowel problem; they required a urine analysis which showed I had "loads of white cells" and was given Bactrum.  I have had no UTI for at least 25 years.  In the meantime, I had chills, fever, and by  Thursday, my temperature was 101 degrees.  if I have an abundance of white blood cells, could the antigens have caused the UTI?
Pt developed crying for 6 hours, post vax, at 2 month immunizations of DTAP, IPV, HIB and PCV. DT was given at 4 months.
The day of my vaccine I was tired more than usual.  The day after my vaccine, the injection site was sore to touch.  My symptoms lasted a couple days.  I took Tylenol for the discomforts.  One week after receiving vaccine,  the injection site was a little red  and warm to the touch, and my right arm was aching. I again, took Tylenol. I also put a heating pad on the injection site, my arm feels better, but the injection  site is still sore to the touch.
pt reported soreness, tenderness of rt arm-entire upper area & swelling which was subsiding;unk whether or not had fever;c/o h/a;had MD appt, MD gave APAP;
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient. A 33 year-old male patient received bnt162b2 (BNT162B2) (Lot number: EW0196, Expiration Date: Dec2021) at the age of 33 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Hypertension" (unspecified if ongoing); "Cirrhosis" (unspecified if ongoing). Concomitant medication(s) included: LEXAPRO. Vaccination history included: Bnt162b2 (Dose:1, single), for COVID-19 Immunization, reaction(s): "break through Covid infection"; Bnt162b2 (Dose:2, single), for COVID-19 Immunization, reaction(s): "break through Covid infection". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), IMMUNISATION (medically significant), outcome "unknown" and all described as "I have a break through Covid infection after having both dosage of the Pfizer vaccine plus the booster.". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: break through covid infection. No follow-up attempts are possible. No further information is expected.
Redness and swelling at the injection site (started off the size of a golf ball diameter, but has increased to the size of a baseball diameter, stretching from one side of arm to the other side); Hot to the touch initially but only warm to the touch now; No itching originally, but some slight itching now; It is less red now
This is a spontaneous report from a contactable physician via a Pfizer sales representative. This physician reported similar events for four patients. This is the fourth of four patients. A male patient of an unspecified age and ethnicity received a single dose of TRUMENBA via an unspecified route of administration, on an unspecified date. The patient  medical history and concomitant medications were not reported. On an unspecified date, the patient experienced huge rash probably like a whole foot long (rash), swelling, very red and warm to touch, severe pain at the injection site that went all the way up to the back of their neck and all the way down to their hands. The events were described as pain at the injection site, large redness and swelling with hotness, radiating pain both to the neck and all the way down to the hands. Therapeutic measures were taken as a result of events and included MOTRIN and BENADRYL. Clinical outcome of the adverse events was unknown at time of this report.  Follow-up (29SEP2016): Follow-up attempts are completed. No further information is expected.
Started out as a localized bruise several days after injection. On Saturday 1/2/21 noticed a pink spot where the bruise occured. The spot was 4 inches long & 2 inches wide. Spot is warm to touch & was itchy. The spot remained the same until 1/5/21. It did not take anything to help with itching
Patient states he experienced shaking, chills and elevated pulse rate for 30 minutes after 8 hours he received vaccine.
patient reports that on Jan 30, 2021 her arm at the injection site got red and itchy
Pt woke up at midnight, roughly 12 hours after receiving KINRIX and PROQUAD and was hallucinating, saying there were bees all over him and in his bed. mom reports no fever, no rash, pt was awake and alert.
Patient fainted after receiving vaccine. Patient said she had history of fainting with other vaccines and blood draws in the past. Patient fainted about 5 minutes after receiving vaccine. Patient fell off the post vaccine chair. Patient was coherent
Delayed reaction to the vaccine; Burning rash all over the body/Burning; Itching/Itchy; Got very aggressive; Rash with a hot feeling; Rush all over his side/Rash appeared on both sides of his body; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Delayed reaction to the vaccine), SKIN BURNING SENSATION (Burning rash all over the body/Burning), PRURITUS (Itching/Itchy), AGGRESSION (Got very aggressive) and FEELING HOT (Rash with a hot feeling) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma and Skin disorder NOS (He had urticarias occasionally.).    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Delayed reaction to the vaccine), SKIN BURNING SENSATION (Burning rash all over the body/Burning), PRURITUS (Itching/Itchy), AGGRESSION (Got very aggressive), FEELING HOT (Rash with a hot feeling) and RASH (Rush all over his side/Rash appeared on both sides of his body). The patient was treated with HYDROCORTISONE at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (Delayed reaction to the vaccine), SKIN BURNING SENSATION (Burning rash all over the body/Burning), PRURITUS (Itching/Itchy), AGGRESSION (Got very aggressive), FEELING HOT (Rash with a hot feeling) and RASH (Rush all over his side/Rash appeared on both sides of his body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
I had a total knee replacement in February 2021.  I experienced significant inflammation in that same knee, calf, ankle and foot as a result of that surgical procedure. Then just 2 days ago, following my first Covid-19 vaccination, I had/am now having an inflammatory response in that same leg (knee, calf, ankle and foot). I reported it to my surgeon Dr.
Fever, chills, leg muscle aches, and shortness of breath. Took 500 mg Tylenol and fever, muscle aches, and chills resolved. However, shortness of breath has started on 2/10 and has not resolved. I have to take deep breaths.
Mother called and said about 4 hours after the shots she was changing and patient suddenly stiffened and then both arms and legs started to move around wildly (not tonic-clonic movements) and then (see enclosed note).
Severe Covid arm began within 15 hours of second shot. It is an enormous red mound that is at once painful and itchy. A bruise appeared under the welt. With the first shot, the reaction was less severe, but it resulted in quite swollen and painful lymph node in armpit that persisted for nearly a month.
I started 6 hours after I got the vaccine a lot of body aches, hypersensitive to pain, out of the ordinary pain sensations.
The pt experienced a rash, erythema, macular papular to hands and thorax, legs and buttocks. No fever was noted.
Upper arm swelling. Advised warm soaks and pt recovered completely. Swelling beyond normal local reaction.
Injection at 1109.  At 1135 c/o of itchiness of hands and forearms.  No other complaints.  Benadryl 25 mg given orally.  Improved--returned to workplace.  At 1250 c/o of worsening symptoms.  Tonsils mildly swollen and mildly erythematous.  No significant swelling fo tongue and no difficulty swallowing.  No redness of skin and no rash noted.  Heart rate 118.  B/P 118/78 Respirations 18. Oxygen Saturation 100% on room air.  I made the decision to send her to the local hospital ER at 1305 as a precaution.  At 1408 in ER she received Benadryl and Epinephrine.  At 1428 she received solumedrol and Pepcid.  Being observed in ER for 4 more hours.
injection site started to itch Tuesday evening.  Wednesday morning arm was swollen, red, very itchy and warm to the touch - symptoms are still occurring on Thursday evening and arm is even redder..